The level of plasma SERPINA3 was significantly higher in CAD group [104.4(54.5–259.2) μg/mL] than that in non-CAD group [65.3(47.5–137.3) μg/mL] (P = 0.004) (Figure 2A). This evidence concerns the gene SERPINA3 and coronary artery disorder.